Large-scale testing (Phase 3)Study completedNCT01846793
What this trial is testing
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Who this might be right for
Benign Prostatic HyperplasiaBPHLower Urinary Tract Symptoms (LUTS)+1 more
Nymox Corporation 160